Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
Status:
Completed
Trial end date:
2018-09-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone
compared with placebo in pediatric outpatients (7-17 years of age) with major depressive
disorder.